Market Closed

MESO
Mesoblast Limited
$ 13.27
1.30%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Mesoblast Limited News

Latest Mesoblast Limited Stock News & MESO Headlines

Mesoblast Posts $115 Million in Revenue, Sets Sights on 2027 Back Pain Trial Readout
4 days ago | marketbeat.com
Use Of Ryoncil First Line After Steroids For Pediatric Acute Graft Versus Host Disease Highlighted In Key Opinion Leader Webinar
11 days ago | globenewswire.com
Mesoblast Board Changes
14 days ago | globenewswire.com
Activity Report for Quarter Ended September 30, 2026 (Appendix 4C)
18 days ago | globenewswire.com
Mesoblast: Ryoncil Helps Fund Rexlemestrocel-L For Back Pain
a month ago | seekingalpha.com
Mesoblast (NASDAQ:MESO) Stock Price Breaks Below 50 Day Moving Average – Should You Sell?
a month ago | defenseworld.net
Mesoblast Receives FDA Approval for New Potency Assay to Release Commercial Ryoncil Product
2 months ago | globenewswire.com
Mesoblast (NASDAQ:MESO) and Biogen (NASDAQ:BIIB) Head-To-Head Contrast
2 months ago | defenseworld.net
Mesoblast (NASDAQ:MESO) Share Price Passes Above 50 Day Moving Average – Time to Sell?
2 months ago | defenseworld.net
Mesoblast Limited (MESO) Q4 2026 Earnings Call Transcript
3 months ago | seekingalpha.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

MESO
Mesoblast Limited
$ 13.27
1.30%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago